Galectin Therapeutics Inc. (GALT)

[thefamilyman]

Thank you for the information. And I had considered that possibility and then dismissed it immediately as too awful to contemplate. Because if our management team actually discussed it and then decided to withhold relevant information from minority shareholders, that is just unconscionable.

The sad thing is that there was no reason for them to withhold that information! It was going to come out anyway when Cohort 2 results were released. And at that point, minority shareholders would then know that they were deliberately kept in the dark. That kind of deliberate disregard for your other investors is not healthy for a pre-revenue biotech because it WILL keep some investors from buying in. Being able to trust that the company's management not only has integrity, but also has your best interest at heart, is very important.

I am convinced that our share price still has not recovered because many in the investment community no longer trust our management. I was hopeful that Traber could be cut loose and GALT might then benefit from a "reset" with the investment community. But if our management team is that incestuous, you are probably right that Traber is here to stay. And therefore, our "Traber Effect" discount share price is also here to stay.

It just gets worse and worse...

familyman, Traber and Czirr are very close friends and are tied at the hip, there isn't going to be any change in the CEO position as long as Czirr is the Executive Chairman of the company and, along with Rod Martin, the largest shareholders.

If they screwed the pooch on Cohort 2 it was a team effort, they all participate in each major decision.
- biotech2010